Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin vs Dinoprostone Induction vs Expectant Management in PROM at Term
NCT02825641Completed
- Sponsor
- Rambam Health Care Campus
- Start
- Aug 2016
- Primary completion
- Nov 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of oxytocin and dinoprostone in premature rupture of membranes (PROM) (4 arms), sponsored by Rambam Health Care Campus. Primary endpoint: Vaginal delivery rate at 7 days. Started Aug 2016; status: completed.
02
Drugs
oxytocindinoprostone
03
Conditions
premature rupture of membranes (PROM)
Beyond the preview
Go deeper on NCT02825641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02825641.